{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:03:36Z","timestamp":1791497016197,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T00:00:00Z","timestamp":1448496000000},"content-version":"vor","delay-in-days":725,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1038\/jid.2013.253","type":"journal-article","created":{"date-parts":[[2013,6,10]],"date-time":"2013-06-10T09:46:59Z","timestamp":1370857619000},"page":"2706-2713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses"],"prefix":"10.1016","volume":"133","author":[{"given":"Christina","family":"Schellenbacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kihyuck","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Shafti-Keramat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Jindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Dillner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.S.","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Kirnbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2013.253_bb0010","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1073\/pnas.0800868105","article-title":"Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2","volume":"105","author":"Alphs","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2013.253_bb0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"key":"10.1038\/jid.2013.253_bb0020","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/jid.2008.123","article-title":"beta-Papillomavirus infection and skin cancer","volume":"128","author":"Bouwes Bavinck","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.253_bb0025","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1016\/j.vaccine.2010.04.049","article-title":"Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7","volume":"28","author":"Caldeira Jdo","year":"2010","journal-title":"Vaccine"},{"key":"10.1038\/jid.2013.253_bb0030","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/viro.1995.1392","article-title":"Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4","volume":"211","author":"Chandrachud","year":"1995","journal-title":"Virology"},{"key":"10.1038\/jid.2013.253_bb0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0168-1702(91)90031-P","article-title":"Neutralization of CRPV infectivity by monoclonal antibodies that identify conformational epitopes on intact virions","volume":"21","author":"Christensen","year":"1991","journal-title":"Virus Res"},{"key":"10.1038\/jid.2013.253_bb0040","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1038\/jid.2013.253_bb0045","doi-asserted-by":"crossref","first-page":"11585","DOI":"10.1128\/JVI.01577-07","article-title":"Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2","volume":"81","author":"Gambhira","year":"2007","journal-title":"J Virol"},{"key":"10.1038\/jid.2013.253_bb0050","doi-asserted-by":"crossref","first-page":"13927","DOI":"10.1128\/JVI.00936-07","article-title":"A protective and broadly cross-neutralizing epitope of human papillomavirus L2","volume":"81","author":"Gambhira","year":"2007","journal-title":"J Virol"},{"key":"10.1038\/jid.2013.253_bb0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1128\/jvi.67.1.315-322.1993","article-title":"Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins","volume":"67","author":"Hagensee","year":"1993","journal-title":"J Virol"},{"key":"10.1038\/jid.2013.253_bb0060","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1099\/vir.0.006189-0","article-title":"Serological relationship between cutaneous human papillomavirus types 5, 8 and 92","volume":"90","author":"Handisurya","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1038\/jid.2013.253_bb0065","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2133.2007.08094.x","article-title":"Human papillomavirus type 26 infection causing multiple invasive squamous cell carcinomas of the fingernails in an AIDS patient under highly active antiretroviral therapy","volume":"157","author":"Handisurya","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2013.253_bb0070","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/jnci\/djp106","article-title":"Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines","volume":"101","author":"Jagu","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/jid.2013.253_bb0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0168-1702(03)00071-6","article-title":"Mucosally-derived HPV-40 can infect both human genital foreskin and cutaneous hand skin tissues grafted into athymic mice","volume":"93","author":"Jenkins","year":"2003","journal-title":"Virus Res"},{"key":"10.1038\/jid.2013.253_bb0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jnci\/djj092","article-title":"Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin","volume":"98","author":"Karagas","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/jid.2013.253_bb0085","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1128\/JVI.01081-10","article-title":"Papillomavirus infection requires gamma secretase","volume":"84","author":"Karanam","year":"2010","journal-title":"J Virol"},{"key":"10.1038\/jid.2013.253_bb0090","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1128\/JVI.73.7.6188-6190.1999","article-title":"Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6","volume":"73","author":"Kawana","year":"1999","journal-title":"J Virol"},{"key":"10.1038\/jid.2013.253_bb0095","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","article-title":"Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic","volume":"89","author":"Kirnbauer","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2013.253_bb0100","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1128\/jvi.67.12.6929-6936.1993","article-title":"Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles","volume":"67","author":"Kirnbauer","year":"1993","journal-title":"J Virol"},{"key":"10.1038\/jid.2013.253_bb0105","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/jmv.21124","article-title":"Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes","volume":"80","author":"Kondo","year":"2008","journal-title":"J Med Virol"},{"key":"10.1038\/jid.2013.253_bb0110","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1468-3083.2010.03814.x","article-title":"Prevalence of benign cutaneous disease among Oxford renal transplant recipients","volume":"25","author":"Lally","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1038\/jid.2013.253_bb0115","doi-asserted-by":"crossref","first-page":"13253","DOI":"10.1128\/JVI.06093-11","article-title":"A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection","volume":"85","author":"Longet","year":"2011","journal-title":"J Virol"},{"key":"10.1038\/jid.2013.253_bb0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.virol.2004.02.011","article-title":"Propagation, infection, and neutralization of authentic HPV16 virus","volume":"322","author":"McLaughlin-Drubin","year":"2004","journal-title":"Virology"},{"key":"10.1038\/jid.2013.253_bb0125","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen? The international perspective","volume":"111","author":"Munoz","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1038\/jid.2013.253_bb0130","doi-asserted-by":"crossref","first-page":"e39741","DOI":"10.1371\/journal.pone.0039741","article-title":"Development of AAVLP(HPV16\/31L2) particles as broadly protective HPV vaccine candidate","volume":"7","author":"Nieto","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/jid.2013.253_bb0135","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1128\/JVI.77.8.4635-4645.2003","article-title":"Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL\/6 mice","volume":"77","author":"Ohlschlager","year":"2003","journal-title":"J Virol"},{"key":"10.1038\/jid.2013.253_bb0140","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/jid.2013.253_bb0145","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.virol.2005.04.011","article-title":"Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2","volume":"337","author":"Pastrana","year":"2005","journal-title":"Virology"},{"key":"10.1038\/jid.2013.253_bb0150","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nm1598","article-title":"Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan","volume":"13","author":"Roberts","year":"2007","journal-title":"Nat Med"},{"key":"10.1038\/jid.2013.253_bb0155","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/viro.2000.0272","article-title":"Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes","volume":"270","author":"Roden","year":"2000","journal-title":"Virology"},{"key":"10.1038\/jid.2013.253_bb0160","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/jvi.67.4.1936-1944.1993","article-title":"Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles","volume":"67","author":"Rose","year":"1993","journal-title":"J Virol"},{"key":"10.1038\/jid.2013.253_bb0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s004030050201","article-title":"Clinical features and age distribution of patients with HPV 2\/27\/57-induced common warts","volume":"289","author":"Rubben","year":"1997","journal-title":"Arch Dermatol Res"},{"key":"10.1038\/jid.2013.253_bb0170","doi-asserted-by":"crossref","first-page":"10085","DOI":"10.1128\/JVI.01088-09","article-title":"Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines","volume":"83","author":"Schellenbacher","year":"2009","journal-title":"J Virol"},{"key":"10.1038\/jid.2013.253_bb0175","doi-asserted-by":"crossref","first-page":"12692","DOI":"10.1128\/JVI.01582-09","article-title":"Identification of B-cell epitopes on virus-like particles of cutaneous alpha-human papillomaviruses","volume":"83","author":"Senger","year":"2009","journal-title":"J Virol"},{"key":"10.1038\/jid.2013.253_bb0180","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.vaccine.2006.11.049","article-title":"A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11","volume":"25","author":"Slupetzky","year":"2007","journal-title":"Vaccine"},{"key":"10.1038\/jid.2013.253_bb0185","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/1523-1747.ep12321173","article-title":"Titration of HPV-11 infectivity and antibody neutralization can be measured in vitro","volume":"105","author":"Smith","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.253_bb0190","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1073\/pnas.92.25.11553","article-title":"Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas","volume":"92","author":"Suzich","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2013.253_bb0195","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.27713","article-title":"Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe","volume":"132","author":"Tjalma","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1038\/jid.2013.253_bb0200","doi-asserted-by":"crossref","first-page":"e49751","DOI":"10.1371\/journal.pone.0049751","article-title":"VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus","volume":"7","author":"Tumban","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/jid.2013.253_bb0205","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2133.2009.09160.x","article-title":"Warts in primary schoolchildren: prevalence and relation with environmental factors","volume":"161","author":"van Haalen","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2013.253_bb0210","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.4049\/jimmunol.177.4.2662","article-title":"Papillomavirus-like particles are an effective platform for amyloid-beta immunization in rabbits and transgenic mice","volume":"177","author":"Zamora","year":"2006","journal-title":"J Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15360498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15360498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T16:29:09Z","timestamp":1743956949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15360498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0022202X15360498"],"URL":"https:\/\/doi.org\/10.1038\/jid.2013.253","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718018886.793485870","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2013.253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}